Based on the effects that social distancing and quarantine are having on current and upcoming clinical studies, decentralization offers many benefits over the traditional approach to clinical trial execution – leveraging digital technology and home health to facilitate site-less trials and patient-centric protocols.
The webinar focuses on:
- Providing a seamless transition from traditional to decentralized, and sometimes site-less, trials
- Managing challenges and obstacles for integrating decentralization into clinical trials
- Moving beyond COVID-19 and the case for facilitating the spectrum of decentralized clinical trials in the future
 |  |  |  |
|---|---|---|---|
| Jimmy El Hokayem, Ph.D., | Marc M. Gas, Ph.D. | Bill Bolgar, Pharm.D., | Sandra Marticio, |
Associate Director of Program Development and Head of the Neurology and Regenerative Medicine Center of Excellence at Biorasi | Head, Dermatology Center of Excellence at Biorasi | Senior Director of Pharmacy Innovation at Coram Clinical Trials | Manager of Business Development at Coram Clinical Trials |
